4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-047559
Chairman and CEO bought 8,300 shares at an average $2.64 ($21,907)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +200 | $2.74 | $548 | 1,050,066 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +2,800 | $2.62 | $7,336 | 1,052,866 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +1,102 | $2.64 | $2,909 | 1,053,968 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +198 | $2.65 | $525 | 1,054,166 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +300 | $2.60 | $780 | 1,054,466 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +800 | $2.62 | $2,096 | 1,055,266 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +200 | $2.63 | $526 | 1,055,466 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +465 | $2.64 | $1,228 | 1,055,931 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +1,100 | $2.65 | $2,915 | 1,057,031 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +100 | $2.66 | $266 | 1,057,131 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +800 | $2.68 | $2,144 | 1,057,931 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +35 | $2.69 | $94 | 1,057,966 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +200 | $2.70 | $540 | 1,058,166 | D |
| Open-market purchases · 8,300 sh · avg $2.64 · $21,907 | |||||||
Loading xslF345X03/doc4.xml…